Brian A. Leuthner has been the Co-Founder, President and CEO of Edge Therapeutics, Inc. since its inception and also serves on the company’s board of directors. He has more than 25 years of experience in the hospital acute care marketplace, with a specific expertise in critical care and neurocritical care. Prior to founding Edge, Brian was the CEO of Fontus Pharmaceuticals, the Senior Head of Marketing for The Medicines Company, and the Director of Market Development for ESP Pharma. He also held marketing and sales positions at Burroughs Wellcome, GlaxoWellcome and Ortho Biotech. In these leadership roles, Brian helped create and advance hospital business units, develop and launch new critical care products, and strengthen customer relationships.
Brian received his B.S. and M.B.A. degrees from the University of North Carolina at Chapel Hill.